ClinicalTrials.gg
CompletedNCT04856462Updated Nov 13, 2026Results posted

The Alzheimer's Companion Engagement (ACE) Project.

An interventional study of Education Support in Stress, Psychological and Adaptation, Psychological, sponsored by University of Michigan. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by University of Michigan · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 13, 2026Results postedStudy documents posted+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 290 studies in Stress, Psychological with a site in United States — 31 open to participants now, 46 under way, 1 of them phase 3. Stress, Psychological · United States.

Enrollment
228th of 262
25 · median 84
Started
2025
with 11 others
No phase
240 of 290
25 open now
Registered
185th of 290
by date

Among the 290 studies in Stress, Psychological with a site in United States, this one is the 228th largest by enrollment of the 262 interventional ones that give a count, is one of 12 that started in 2025, is one of 240 with no phase, and was the 185th registered.

Stress, Psychological

854 studies on the registry are indexed under Stress, Psychological; 141 are open to participants now.

Browse Stress, Psychological studies →

Open to participants now

31 of the 290 studies in Stress, Psychological with a site in United States are open now. Recruiting first, the newest first:

26 more — sign in →

All 31 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 74 Stress, Psychological studies recruiting now, 34 (46%) set no upper age limit and 36 (49%) stop at 75 or younger; 13 take children under 18; 49 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 290 studies in Stress, Psychological with a site in United States, or all of them as a file.
02

Study summary

Black family caregivers of older adults with Alzheimer's disease and/or related dementias (ADRD), have an increased mortality risk related to pre-existing health conditions and stress. Targeted, culturally responsive, health interventions that help Black ADRD caregivers to effectively manage their own health and use community preferenced ways of coping, can improve caregivers' overall health, perceived ability to provide care for a person with ADRD (self-efficacy), and increases the likelihood that they will experience benefits from caregiving. This clinical trial pilot will test the feasibility of a community based intervention designed to improve health outcomes for Black family caregivers of persons with ADRD.

Read the detailed description

The proposed intervention is a peer-supportive and facilitator-led video teleconference program that will engage small groups of caregivers weekly over 6 weeks. Each week participants (n = 36, 2-5/group) will receive a different culturally relevant caregiving or personal health strategy to practice. During the support calls, a facilitator will provide an overview of the content covered and each participant will have the opportunity to discuss their past week and how they engaged the weekly strategy, or challenges that came up for them during the week. The format will be structured to ensure that core content is reviewed, and everyone can be equally engaged while flexible enough that caregivers can receive support in the areas they need. A battery of assessment measures will be taken at weeks 1 and 8.

03

Conditions studied

  • Stress, Psychological
  • Adaptation, Psychological

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion criteria for participation are as follows:

Self-identified as Black/ African American At least 18 years old Able to speak, understand, and hear spoken English Related to, or has a close personal relationship to a person over the age of 55 that has an ADRD diagnosis or evidence of cognitive impairment Regular access to a smartphone, tablet or computer with internet access that will allow video conferencing engagement.

Provides monitoring, and assistance in activities of daily living and or other care tasks for the care recipient.

-

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (actual)

Study arms

  • Experimental
    Caregiver Support

    All participants in all groups will receive 6 weeks of caregiving support including a weekly video/teleconference call, and handouts covering relevant educational topics)

    Behavioral: Education Support

Interventions

  • BehavioralEducation Support

    Caregivers engage in a weekly video/teleconference support group with a skilled facilitator to discuss various strategies for managing caregiving stress, challenging behaviors, and personal self-care.

06

What researchers measure

Primary outcomes

  1. Caregiver Self-efficacy for Obtaining Respite Care

    Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline.

    Time frame: 6 weeks

  2. Caregiver Self-Efficacy for Controlling Upsetting Thoughts

    Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline.

    Time frame: 6 Weeks

  3. Caregiver Self-Efficacy for Responding to Disruptive Behaviors

    Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline.

    Time frame: 6 Weeks

Secondary outcomes

  1. Positive Aspects of Caregiving

    The Positive Aspects of Caregiving tool is a brief assessment measure that asks questions about caregiving experiences that made the caregiver feel good about providing care. Responses are rated from 1, disagree a lot, to 5, agree a lot. Scores range from 9 to 45 with higher scores indicating more positive experiences related to family caregiving.

    Time frame: 6 weeks

07

Results

Posted Nov 13, 2026

Participant flow

Participants were recruited using a study flyer distributed through organizations servicing older adults and persons with dementia in the metro detroit. A Facebook marketing campaign was also completed. Screening surveys were completed by 513 potential participants. Screening and recruitment took place between March 2025 and August 2025.

Participant flow — Overall Study
MilestoneCaregiver Support
Started25
Completed23
Not completed2

Outcome measures

PrimaryCaregiver Self-efficacy for Obtaining Respite Care

Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline.

Time frame:
6 weeks
Reported as:
Mean · percent
Caregiver Self-efficacy for Obtaining Respite Care
percentCaregiver Support
Caregiver Self-efficacy for Obtaining Respite Care85.21 (78.12 to 92.31)
Statistical analysis
  • Caregiver Support · t-test, 2 sided · p = 0.180
SecondaryPositive Aspects of Caregiving

The Positive Aspects of Caregiving tool is a brief assessment measure that asks questions about caregiving experiences that made the caregiver feel good about providing care. Responses are rated from 1, disagree a lot, to 5, agree a lot. Scores range from 9 to 45 with higher scores indicating more positive experiences related to family caregiving.

Time frame:
6 weeks
Reported as:
Mean · points
Positive Aspects of Caregiving
pointsCaregiver Support
Positive Aspects of Caregiving33.47 (28.69 to 38.27)
Statistical analysis
  • Caregiver Support · t-test, 2 sided · p = 0.106
PrimaryCaregiver Self-Efficacy for Controlling Upsetting Thoughts

Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline.

Time frame:
6 Weeks
Reported as:
Mean · Percent
Caregiver Self-Efficacy for Controlling Upsetting Thoughts
PercentCaregiver Support
Caregiver Self-Efficacy for Controlling Upsetting Thoughts85.21 (78.12 to 92.31)
Statistical analysis
  • Caregiver Support · t-test, 2 sided · p = 0.248
PrimaryCaregiver Self-Efficacy for Responding to Disruptive Behaviors

Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline.

Time frame:
6 Weeks
Reported as:
Mean · Percent
Caregiver Self-Efficacy for Responding to Disruptive Behaviors
PercentCaregiver Support
Caregiver Self-Efficacy for Responding to Disruptive Behaviors82 (76.36 to 87.64)
Statistical analysis
  • Caregiver Support · t-test, 2 sided · p = 0.401

Adverse events

Collected over From enrollment until the end of follow-up, up to 8 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Caregiver Support0/25 (0%)0/25 (0%)0/25 (0%)

Baseline characteristics

Complete data is available for 22-23 participants, depending on the measure

Age, Continuous
Age, Continuous(years)Caregiver Support
Mean54.74 ± 10.79
Sex: Female, Male
Sex: Female, Male(Participants)Caregiver Support
Female18
Male5
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Caregiver Support
American Indian or Alaska Native0
Asian0
Native Hawaiian or Other Pacific Islander0
Black or African American23
White0
More than one race0
Unknown or Not Reported0
Caregiver Self-Efficacy
Caregiver Self-Efficacy(Percentage)Caregiver Support
Self-Efficacy in Obtaining Respite Care74.17 ± 35.23
Self-Efficacy in Controlling Obsetting Thoughts89.45 ± 98.68
Self-Efficacy in Responding to Disruptive Behavior84.35 ± 15.67
Positive Aspects of Caregiving Scale
Positive Aspects of Caregiving Scale(points)Caregiver Support
Mean33.38 ± 10.41
08

Study locations

1 site
  • University of Michigan
    Ann Arbor, Michigan 48109, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — It is anticipated that the following data will be generated and made available 1) published tables, figures, graphs, and tables of data used for making graphs; 2) published journal papers, conference papers, annual reports and the final report; and 3) educational materials resulting from intervention development. All data will conform with relevant data and terminology standards.

Supporting information: Study protocol, Statistical analysis plan, Clinical study report, Analytic code

Time frame: No less than 5 years following the date of the project completion or the date of study publication.

Access criteria: To facilitate data sharing, project data will be made publicly available via a university-managed repository Deep Blue.

Data sharing details ↗ · deepblue.lib.umich.edu

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2025 to primary completion in Oct 2025, 7 months.

Results were first posted in Nov 2026, 1 year after primary completion.

Of 462 non-industry interventional studies with no phase under Stress, Psychological, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's 7 months is below that.

Counting every sponsor, half of 475 studies reached it within 13 months; a quarter within 5 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 19, 2021
First posted
Apr 23, 2021
StartActual
Mar 6, 2025
Primary completionActual
Oct 22, 2025
CompletionActual
Oct 22, 2025
Results first posted
Nov 13, 2026
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Nov 13, 2026
Primary outcomes
1 edited, 2 added
What changed in the outcomes
  • EditedCaregiver Self-efficacy for Obtaining Respite CareTime frame: 6 weeks
  • AddedCaregiver Self-Efficacy for Controlling Upsetting ThoughtsTime frame: 6 Weeks
  • AddedCaregiver Self-Efficacy for Responding to Disruptive BehaviorsTime frame: 6 Weeks
Nov 13, 2026
Documents
Secondary outcomes
1 description edited
What changed in the outcomes
  • DescriptionPositive Aspects of Caregiving: how it is measured was reworded
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    Results posted
    Primary outcomes 1 edited, 2 added
    What changed in the outcomes
    • EditedCaregiver Self-efficacy for Obtaining Respite CareTime frame: 6 weeks
    • AddedCaregiver Self-Efficacy for Controlling Upsetting ThoughtsTime frame: 6 Weeks
    • AddedCaregiver Self-Efficacy for Responding to Disruptive BehaviorsTime frame: 6 Weeks
    Secondary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionPositive Aspects of Caregiving: how it is measured was reworded
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT04856462
Responsible party
Sheria Robinson-Lane (Associate Professor, University of Michigan) — Principal investigator
First posted
Apr 23, 2021
Start date
Mar 6, 2025
Primary completion
Oct 22, 2025
Completion
Oct 22, 2025
Results posted
Nov 13, 2026
Last update
Nov 13, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion